Author/Authors :
Poortahmasebi, Vahdat Department of Virology - School of Public Health - Tehran University of Medical Sciences, Tehran, Iran , Emami Aleagha, Mohammad Sajad Department of Clinical Biochemistry - Faculty of Medical Sciences - Tarbiat Modares University, Tehran, Iran , Amiri, Mehdi Department of Cell Biology and Anatomy - Schulich School of Medicine and Dentistry, Western University, London, ON, Canada , Qorbani, Mostafa Department of Community Medicine - Alborz University of Medical Sciences, Karaj, Iran , Farahmand, Mohammad Virology Department - School of Public Health - Tehran University of Medical Sciences, Tehran, Iran , Asayesh, Hamid Department of Medical Emergencies - Qom University of Medical Sciences, Qom, Iran , Alavian, Moayed Gastroenterology and Hepatology - Middle East Liver Diseases (MELD) Center, Tehran, Iran
Abstract :
Background: Hepatic steatosis is commonly observed in patients with chronic hepatitis C (CHC).
Many studies indicate a relationship between steatosis and fibrosis progression. The aim of this study
was to analyze the prevalence of hepatic steatosis and related factors in Iranian CHC patients.
Methods: One hundred and fifteen consecutive patients with CHC were enrolled which were treatment-
naïve. The patients were divided into groups with and without steatosis according to the result
of liver biopsy (58.3% and 41.7%, respectively). Demographic, histological, biochemical and virological
factors were examined and compared in all patients.
Results: In terms of host factors, body mass index (BMI), triglyceride, fasting blood glucose
(FBG), necroinflammatory activity and severity in fibrosis of CHC patients with steatosis was significantly
higher than the patients without steatosis. Of viral factors, HCV viral load was not significantly
altered in patients with steatosis. Moreover, HCV genotypes did not meet such association.
Using multivariate regression analysis, parameters of BMI values, FBG level and stage of fibrosis
were independently associated with steatosis.
Conclusion: Our data indicate that CHC patients are more susceptible to development of hepatic
steatosis. Based on our results, grade of steatosis appears to be associated with hepatic fibrosis progression
rate in CHC patients.
Keywords :
Necroinflammatory activity , Fibrosis , Steatosis , Chronic hepatitis C